Oxford BioDynamics is actively engaged in the development of new diagnostic products, based on the EpiSwitch™ technology.
The Company is developing a network of regional licensees in South-East Asia, Australia, Europe and the USA, to commercialise its technology in different diagnostic and therapeutic areas. The Company is proactively looking at specific diseases and drug treatments where the EpiSwitch™ technology brings immediate solutions to cases of high unmet clinical needs.
